StablecoinX Inc. Announces Closing of Business Combination with TLGY Acquisition Corp. and Commencement of Trading on Nasdaq

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) —  StablecoinX Inc. (Nasdaq: USDE) (“StablecoinX” or the “Company”), the first public stablecoin infrastructure company focusing on the Ethena digital dollar ecosystem, today announced the closing of its business combination with TLGY Acquisition Corp. (OTCPK: TLGYF) (“TLGY”), a publicly traded special purpose acquisition company.

“We Will Create God and Then Ask It for Money.”

A Bloomberg columnist accidentally wrote the best summary of the AI bubble ever put to paper. A former Pentagon advisor explains why it’s not actually funny.

A Bloomberg columnist accidentally wrote the best summary of the AI bubble ever put to paper. A former Pentagon advisor explains why it's not actually funny.

PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026

MINNEAPOLIS, MN, US, June 25, 2026 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, will report financial results for the year ending March 31, 2026, on Monday, June 29, 2026 after market close. The company will host a conference call to discuss these results at 5:00 p.m. CT (6:00 p.m. ET) on the same day.

SEDA Expands Investment Banking and Capital Markets Expertise with the Addition of Ignacio Maldonado Trinchant

SEDA Experts LLC, a leading expert witness firm providing world-class financial expert witness services, announced today that Ignacio Maldonado Trinchant joined the firm as Managing Director.

SEDA Experts LLC, a leading expert witness firm providing world-class financial expert witness services, announced today that Ignacio Maldonado Trinchant joined the firm as Managing Director.

IgA Nephropathy Clinical Trial Space Intensifies with 25+ Companies in Active Development | DelveInsight

The IgA nephropathy clinical trial analysis report delivers important insights into ongoing research of 30+ pipeline IgA nephropathy drugs, clinical strategies, upcoming therapeutics, and commercial analysis.

The IgA nephropathy clinical trial analysis report delivers important insights into ongoing research of 30+ pipeline IgA nephropathy drugs, clinical strategies, upcoming therapeutics, and commercial analysis.

Zoomcar Announces Extension of Offer to Exchange Outstanding Warrants for Common Stock

Bengaluru, India, June 25, 2026 (GLOBE NEWSWIRE) — Zoomcar Holdings, Inc. (OTCQB: ZCAR) (the “Company”), the leading peer-to-peer self-drive car-sharing marketplace in India, today announced that it is extending the expiration date of its previously announced offer to exchange (the “Offer to Exchange”) certain outstanding warrants for shares of the Company’s common stock.

Zoomcar Announces Extension of Offer to Exchange Outstanding Warrants for Common Stock

Bengaluru, India, June 25, 2026 (GLOBE NEWSWIRE) — Zoomcar Holdings, Inc. (OTCQB: ZCAR) (the “Company”), the leading peer-to-peer self-drive car-sharing marketplace in India, today announced that it is extending the expiration date of its previously announced offer to exchange (the “Offer to Exchange”) certain outstanding warrants for shares of the Company’s common stock.